Role of Interleukins and Nitric Oxide Secretion by Peritoneal Macrophages in Differential Tumoricidal Effect to Transplantable Melanomas as Regarding their Biological Properties

REFERENCES

• Nakamura K., Okamura H., Wada M., Nagata K., Tamura T. Endotoxin-induced serum factor that stimulates gamma interferon production. Infect. Immun 1989; 57(2)590–595
   PubMed Web of Science ®Google Scholar
• Okamura H., Kashiwamura S., Tsutsui H., Yoshimoto T., Nakanishi K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr. Opin. Immunol 1998; 10(3)259–264
   PubMed Web of Science ®Google Scholar
• Vida l-Vanaclocha F., Fantuzzi G., Mendoza L., Fuentes A.M., Anasagasti M.J., Martin J., Carrascal T., Walsh P., Reznikov L.L., Kim S.H., Novick D., Rubinstein M., Dinarello C.A. IL-18 regulates IL-1β-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc. Natl. Acad. Sci. USA 2000; 97(2)734–739
   PubMed Web of Science ®Google Scholar
• Bomirski A., Dominiczak T., Nowińska L. Spontaneous transplantable melanoma in golden hamster. Acta Union Int. Cancer 1962; 18: 178–180
   PubMedGoogle Scholar
• Hashimoto W., Osaki T., Okamura H., Robbins P.D., Kurimoto M., Nagata S., Lotze M.T., Tahara H. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand-and-perforin-induced tumor apoptosis, respectively. J. Immunol 1999; 163(2)583–589
   PubMed Web of Science ®Google Scholar
• Nagai H., Hara I., Horikawa T., Fujii M., Kurimoto M., Kamidono S., Ichihashi M. Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18. Cancer Invest 2000; 18(3)206–213
   PubMed Web of Science ®Google Scholar
• Osaki T., Hashimoto W., Gambotto A., Okamura H., Robinns P.D., Kurimoto M., Lotze M.T., Tahara H. Potent antitumor effects mediated by local expression of the mature form of the interferon-γ inducing factor, interleukin-18 (IL-18). Gene Ther 1999; 6(5)808–815
   PubMed Web of Science ®Google Scholar
• Yamamoto Y., Kato Z., Matsukuma E., Li A., Omoya K., Hashimoto K., Ohnishi H., Kondo N. Generation of highly stable IL-18 based on a ligand-receptor complex structure. Biochem. Biophys. Res. Commun 2004; 317(1)181–186
   PubMed Web of Science ®Google Scholar
• Coughlin C.M., Wysocka M., Trinchien G., Lee W.M. The effect of interleukin 12 desensitization on the antitumor efficacy of recombinant interleukin 12. Cancer Res 1997; 57(12)2460–2467
   PubMed Web of Science ®Google Scholar
• Coughlin C.M., Salhany K.E., Wysocka M., Aruga E., Kurzawa H., Chang A.E., Hunter C.A., Fox J.C., Trinchieri G., Lee W.M. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Invest 1998; 101(6)1441–1452
   PubMed Web of Science ®Google Scholar
• Lebel-Binay S., Berger A., Zinzindohoue F., Ugnenc P.H., Thiounn N., Fridman W.H., Pages F. Interleukin-18: biological properties and clinical implications. Eur. Cytokine Netw 2000; 11(1)15–26
   PubMed Web of Science ®Google Scholar
• Wang Q., Yu H., Zhang L., Ju D., Pan J., Xia D., He L., Wang J., Cao X. Vaccination with IL-18 gene-modified, superantigen-coated tumor cells elicits potent antitumor immune response. J. Cancer Res. Clin. Oncol 2001; 127(12)718–726
   PubMed Web of Science ®Google Scholar
• Carrascal M.T., Mendoza L., Valcarcel M., Salado C., Egilegor E., Telleria N., Vidal-Vanaclocha F., Dinarello C.A. Interleukin-18 binding protein reduces B16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium. Cancer Res 2003; 63(2)491–497
   PubMed Web of Science ®Google Scholar
• Park H., Byun D., Kim T.S., Kim Y.S., Kang J.I., Hahm E.S., Kim S.H., Lee W.J., Song H.K., Yoon D.Y., Kang C.J., Lee C., Honh D., Kim H., Cho B., Kim Y., Yang Y.H., Min K.A., Cho D.H. Enhanced IL-18 expression in common skin tumors. Immunol. Lett 2001; 79(3)215–219
   PubMed Web of Science ®Google Scholar
• Cavallo F., Signorelli P., Mirella G., Musiani P., Modesti A., Brunda M.J., Colombo M.P., Forni G. Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. J. Natl. Cancer Inst 1997; 89(14)1049–1058
   PubMedGoogle Scholar
• Chen L., Chen D., Block E., O’Donnell M., Kufe D.W., Clinton S.K. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer. J. Immunol 1997; 159(1)351–359
   PubMed Web of Science ®Google Scholar
• Tahara H., Zeh H.J., Storkus W.J., Pappo I., Watkins S.C., Gubler U., Wolf S.F., Robbins P.D., Lotze M.T. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res 1994; 54(1)182–189
   PubMed Web of Science ®Google Scholar
• Tahara H., Lotze M.T. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer. Gene Ther 1995; 2(2)96–106
   PubMed Web of Science ®Google Scholar
• Li J., Billiar T.R., Talanian R.V., Kim Y.M. Nitric Oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem. Biophys. Res. Commun 1997; 240(2)419–424
   PubMed Web of Science ®Google Scholar
• Kozłowska K., Cichorek M., Zarzeczna M. Influence of transplantable melanomas on the secretion of cytokines by hamster peritoneal macrophages. Arch. Immunol. Ther. Exp 1999; 47(6)361–365
   PubMedGoogle Scholar
• Kito T., Kuroda E., Yokota A., Yamashita U. Cytotoxicity in glioma cells due to interleukin-12 and interleukin-18 stimulated macrophages mediated by interferon-gamma-regulated nitric oxide. J. Neurosurg 2003; 98(2)385–392
   PubMed Web of Science ®Google Scholar
• Matsuura M., Saita S., Hirai Y., Okamura H. A pathway trough interferon-γ is the main pathway for induction of nitric oxide upon stimulation with bacterial lipopolysaccharide in mouse peritoneal cells. Eur. J. Biochem 2003; 270(19)4016–4025
   PubMedGoogle Scholar
• Kozłowska K., Żurawska-Czupa B., Mierzewski P., Kostulak A. Use of macrophages migration inhibition test to evaluate antigenic differences in golden hamster transplantable melanomas. Int. J. Cancer 1980; 26(2)211–215
   PubMed Web of Science ®Google Scholar
• Kozłowska K., Cichorek M., Zarzeczna M. Implication of macrophage NO and cytokine secretion in the cytotoxicity of transplantable melanomas as regards the progression of these tumors. Int. J. Immunopathol. Pharmacol 2000; 13(2)69–76
   PubMed Web of Science ®Google Scholar
• 25. Bomirski, A. Biological properties of transplantable melanomas in the Syrian hamster during 16 years of maintenance by several passages. Medical Academy, Gdańsk 1977
   Google Scholar
• Kozłowska K., Żurawska-Czupa B., Kostulak A. Comparison of the antigenecity of melanotic and amelanotic melanoma cells after the release of surface glycoproteins by trypsin. Arch. Immunol. Ther. Exp 1980; 28(4)641–644
   PubMed Web of Science ®Google Scholar
• Bomirski A, Kozłowska K, Żurawska-Czupa B. An attempt to prepare nonenzymatically a single cell suspension from solid transplantable melanomas. Abstract. 9th Int. Pigment Cell Conference, TX, Houston, 1975; 5–6
   Google Scholar
• Żurawska-Czupa B., Kozłowska K. A simple method for obtaining pure fraction of hamster peritoneal macrophages. Arch. Immunol. Ther. Exp. 1978; 26(1–6)441–443
   PubMed Web of Science ®Google Scholar
• Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227(5289)680–685
   PubMedGoogle Scholar
• Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen. J. Immunol 1988; 141(7)2407–2412
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Meth. 1983; 65(1–2)55–63
   PubMed Web of Science ®Google Scholar
• Veenstra K.G., Jonak Z.L., Trulli S., Gollob J.A. IL-12 induces monocyte IL-18 binding protein expression via IFN-γ1. J. Immunol 2002; 168(5)2282–2287
   PubMed Web of Science ®Google Scholar
• Cho D., Song H., Kim Y.M., Houh D., Park B.Y., Hur H., Yoon D., Pyun K.H., Lee W.J., Kurimoto M., Kim Y.B., Choi Y.S., Kim I. Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates. Cancer Res 2000; 60(10)2703–2709
   PubMed Web of Science ®Google Scholar
• Nakamura S., Otani T., Ijiri Y., Motoda R., Kurimoto M., Orita K. IFN-γ-dependent and-independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12. J. Immunol 2000; 164(6)3330–3336
   PubMed Web of Science ®Google Scholar
• Zhang T., Kawakami K., Qershui M.H., Okamura H., Kurimoto M., Saito A. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of the murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect. Immun 1997; 65(9)3594–3599
   PubMed Web of Science ®Google Scholar
• Abbas A., Lichtman A. Cellular and Medical Immunology. Saunders, Philadelphia 2003; 243–274
   Google Scholar
• Snijders A., Hilkens C.M., van der Pouwkraan T.C., Engel M., Aarden L.A., Kapsenberg M.L. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by expression of the p53 subunit. J. Immunol 1996; 156(3)1207–1212
   PubMed Web of Science ®Google Scholar
• Hayes M.P., Wang J., Norcross M.A. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-γ of lipopolysaccharide-inducible p53 and p40 genes. Blood 1995; 86(2)646–650
   PubMed Web of Science ®Google Scholar
• Kim Y.M., Talanian R.V., LI J., Billiar T.R. Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme). J. Immunol 1998; 161(8)4122–4128
   PubMed Web of Science ®Google Scholar